Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCrimson Tide Regulatory News (TIDE)

Share Price Information for Crimson Tide (TIDE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.50
Bid: 155.00
Ask: 170.00
Change: 0.00 (0.00%)
Spread: 15.00 (9.677%)
Open: 162.50
High: 162.50
Low: 162.50
Prev. Close: 162.50
TIDE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Signed agreement with Microsoft

17 Oct 2012 07:00

RNS Number : 8455O
Crimson Tide PLC
17 October 2012
 



Crimson Tide PLC

("Crimson Tide" or "the Company")

CRIMSON TIDE IS READY TO OFFER ITS MPRO5 MOBILE SOLUTION WITH ENHANCED SECURITY AND AVAILABILITY WITH WINDOWS AZURE

 

Crimson Tide is a leading developer of cloud-based mobile business applications

 

Crimson Tide today announced that it has signed an agreement to use Microsoft's cloud platform, Windows Azure, as the foundation of the company's mpro business applications. Crimson Tide's latest version of mobility software, mpro 5, offers compatibility with iOS, Android and upcoming Windows 8 smartphones and tablets, and integrates with Windows Azure to provide current and future customers with the most secure, reliable and robust enterprise application available.

Windows Azure provides robust mechanisms for scalability, availability, and security of cloud applications. Windows Azure runs in Microsoft datacentres that have world class security controls in place backed by independent security certifications and attestations. Privacy and safeguarding of customer data are of utmost importance to Microsoft, which is why Windows Azure is offering to sign E.U. Model Contractual Clauses for its core services to provide additional contractual guarantees around transfers of personal data. This is especially important for Crimson Tide's customers involved in the healthcare sector, where securing patient information is fundamental to application development.

"By launching our mpro5 solution on Microsoft's Windows Azure platform I believe that we will be offering one of the most powerful, reliable and adaptable enterprise applications currently on the market," said Barrie Whipp, Executive Chairman, Crimson Tide. "As a company we strive to make continual enhancements and improvements to our system to ensure that our customers are provided with a world class platform. By working with Microsoft I am confident that Windows Azure will provide our mpro5 users with market leading functionality and significant value."

"With Windows Azure Mobile Services, developers can easily connect a cloud back end to client and mobile applications that can use data across devices and users," said Bill Hamilton, Director, Windows Azure Marketing, Microsoft. "Crimson Tide's mpro5 solution takes advantage of Windows Azure Mobility Services to give customers the global scale, security and reliability inherent in the Windows Azure cloud."

- ends -

 

 

 

For further information:

Crimson Tide plc.

Barrie Whipp, Executive Chairman

01892 542 444

WH Ireland

James Joyce

James Bavister

 

020 7220 1666

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAZMMMGNVDGZZM
Date   Source Headline
29th Jan 20197:00 amRNSTrading Update
2nd Nov 20182:08 pmRNSExercise Of Options
4th Oct 20184:47 pmRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
20th Sep 20187:00 amRNSContract Wins and Recruitment
5th Jul 20188:38 amRNSmpro5 healthcare update
2nd Jul 201811:21 amRNSResult of AGM
7th Jun 20188:28 amRNSFinal Results and Notice of AGM
24th Apr 20187:00 amRNSChange of Adviser
13th Apr 20187:00 amRNSPreliminary Results to 31 December 2017
28th Mar 20187:00 amRNSAppointment of new CEO
27th Feb 20187:00 amRNSTrading Statement
19th Dec 20173:44 pmRNSDirector/PDMR Shareholding
15th Dec 201711:30 amRNSExercise of Options
8th Dec 20173:37 pmRNSResult of GM
23rd Nov 20177:00 amRNSNotice of GM
24th Oct 20177:00 amRNSSeries of contract wins for mpro5
17th Oct 20177:00 amRNSDirectorate Change
7th Sep 20177:00 amRNSInterim Results
11th Jul 20177:00 amRNSSignificant mpro5 Contract Win in the Netherlands
29th Jun 20175:47 pmRNSResult of AGM
6th Jun 20172:00 pmRNSFinal Results and Notice of AGM
30th May 20177:00 amRNSInternational Expansion Update
30th Mar 20177:00 amRNSPreliminary Results
2nd Feb 20177:00 amRNSUpdate on International Expansion
14th Dec 20167:00 amRNSTrading Update and Contract Rollout
18th Nov 20169:45 amRNSDirector/PDMR Shareholding
13th Oct 20167:00 amRNSSignificant long term contract win
12th Oct 20167:00 amRNSLong Term Contract with NCHCD
22nd Sep 20167:00 amRNSInterim Results
18th Jul 20167:00 amRNSCrimson Tide selected by large UK retailer
14th Jul 20167:00 amRNSPharmaceutical Verification Pilot
29th Jun 20168:31 amRNSResult of AGM
14th Jun 20167:00 amRNSMpro5 Contract Win
3rd Jun 20163:47 pmRNSFinal Results and Notice of AGM
20th May 20163:26 pmRNSExercise of Options
20th Apr 20167:00 amRNSPreliminary Results
25th Feb 20167:00 amRNSTrading Update
24th Feb 20163:34 pmRNSResult of Court Hearing
26th Jan 20162:37 pmRNSResult of General Meeting
30th Dec 20157:00 amRNSProposed Reconstruction of Capital
4th Dec 20157:00 amRNSUpdate on Significant Contract Win
7th Oct 20155:58 pmRNSHolding(s) in Company
1st Oct 20152:45 pmRNSDirector's Dealing
30th Sep 20157:00 amRNSInterim Results
17th Sep 20157:00 amRNSSignificant contract win
1st Jul 20157:00 amRNSResult of AGM
8th Jun 20157:00 amRNSFinal Results and Notice of AGM
4th Jun 20157:00 amRNSSignificant Contract Win
14th Apr 20157:00 amRNSContracts Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.